Oral hypoglycaemic agents and insulin therapy.
D001645:Biguanides / Q000009:adverse effects / Q000627:therapeutic use*; D003920:Diabetes Mellitus / Q000188:drug therapy*; D006801:Humans; D007328:Insulin / Q000627:therapeutic use*; D013453:Sulfonylurea Compounds / Q000009:adverse effects / Q000627:therapeutic use*
D001645:Biguanides; D007328:Insulin; D013453:Sulfonylurea Compounds